BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8633487)

  • 21. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colonic "precancer" in Crohn's disease.
    Craft CF; Mendelsohn G; Cooper HS; Yardley JH
    Gastroenterology; 1981 Mar; 80(3):578-84. PubMed ID: 7450448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical conference: Unusual course of chronic colitis.
    König H; Hermanek P; Rösch W
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):227-31. PubMed ID: 941626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():24-30. PubMed ID: 15352890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer in Crohn's disease.
    Friedman S
    Gastroenterol Clin North Am; 2006 Sep; 35(3):621-39. PubMed ID: 16952744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chron's disease and cancer].
    Fornaro R; Frascio M; Denegri A; Stabilini C; Impenatore M; Mandolfino F; Lazzara F; Gianetta E
    Ann Ital Chir; 2009; 80(2):119-25. PubMed ID: 19681293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
    Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
    Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crohn's colitis with carcinoma and dysplasia. Report of a case and review of 100 small and large bowel resections for Crohn's disease to detect incidence of dysplasia.
    Warren R; Barwick KW
    Am J Surg Pathol; 1983 Mar; 7(2):151-9. PubMed ID: 6859390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperplastic-like mucosal change in Crohn's disease: an unusual form of dysplasia?
    Kilgore SP; Sigel JE; Goldblum JR
    Mod Pathol; 2000 Jul; 13(7):797-801. PubMed ID: 10912940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk of cancer in chronic inflammatory bowel diseases].
    Fischbach W
    Leber Magen Darm; 1992 May; 22(3):96-101. PubMed ID: 1625513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Crohn's disease and intestinal cancer. A report of 5 cases and review of the literature (author's transl)].
    Otto HF; Bettmann I; von Weltzien JV
    Z Gastroenterol; 1980 Nov; 18(11):583-93. PubMed ID: 7467620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Smoking and inflammatory bowel disease: an epidemiological case-control study].
    Martins Júnior EV; Araújo IS; Atallah AN; Miszputen SJ
    Arq Gastroenterol; 1996; 33(2):74-8. PubMed ID: 9109972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
    Cucino C; Sonnenberg A
    Am J Gastroenterol; 2001 Jul; 96(7):2107-12. PubMed ID: 11467640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.